touchONCOLOGY joins Dr Deborah Doroshow to discuss the recent COVID-19 and Cancer Outcomes Study (CCOS), and how the COVID-19 pandemic has caused disparities in cancer care. Dr Doroshow presented her late-breaking abstract, ‘Disparities in cancer during the COVID-19 pandemic: COVID-19 and cancer outcomes study (CCOS)‘ (LBA74) at the Virtual 2020 ESMO Congress, 19–21 September 2020.
- What were the biggest challenges faced by cancer care providers during the COVID-19 pandemic? (0:14)
- What factors predispose cancer patients to increased risk for COVID-19-related morbidity and mortality? (1:12)
- Could you tell us about the aims and design of the CCOS study? (2:23)
- What were the major findings of the study? (5:01)
- What are the reasons for these disparities and what can be done to mitigate the effects of COVID-19? (6:02)
- Is there anything you would like to highlight in relation to the CCOS study? (7:22)
Speaker Disclosure: Deborah Doroshow has nothing to disclose in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the Virtual 2020 ESMO Congress.
Share this Video
Related Videos In COVID-19
Mark Lawler, European Cancer Summit 2020 – Impact of COVID-19 on Cancer
The COVID-19 pandemic has had a huge impact on us all, but particularly patients with cancer. Prof. Mark Lawler tells touchONCOLOGY about the data he presented at this year’s European Cancer Summit, the challenges patients with cancer face as a result of the pandemic, and steps taken to help mitigate this effect. Questions You presented […]
Florence Joly, ESMO 2020 – Impact of the COVID-19 Pandemic on Cancer Treatments and the Psychological Impact on Patients
The COVID-19 pandemic has had a direct impact on cancer care. Prof. Florence Joly discusses the challenges and lessons learned when treating patients with cancer during the pandemic and lockdown period. The late-breaking abstract ‘Impact of the COVID-19 pandemic on management of medical cancer treatments and psychological consequence for the patients’ (LBA69) was presented at […]
Trisha M Wise-Draper, ESMO 2020 – The COVID-19 and Cancer Consortium Registry (CCC19) and Systemic Cancer Treatment-related Outcomes in Patients with SARS-CoV-2 Infection
Assoc. Prof. Trisha Wise-Draper joins touchONCOLOGY to discuss the impact of the COVID-19 in cancer care and lessons learned through the findings of the COVID-19 and Cancer Consortium Registry (CCC19). The late-breaking abstract ‘Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis’ (LBA71) was presented at the Virtual 2020 ESMO Congress, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!